Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor
Langenbecks Arch Surg. 2010 Feb;395(2):185-92.
Stoeltzing O, Loss M, Huber E, Gross V, Eilles C, Mueller-Brand J, Schlitt HJ.
La terapia DOTA-D-Phe [(1)-Tyr (3)-octreotide (DOTATOC)] potrebbe rivelarsi utile per il trattamento di tumori avanzati neuroendocrini pancreatici (NET) con metastasi al fegato.
Octreotide (DOTATOC)/tumori neuroendocrini pancreatici con metastasi al fegato.